Ricardo Cb Moraes

Ricardo Cb Moraes

Auto-generated profile, based on publicly available information

Ricardo Cb Moraes

Center for Cell and Gene Therapy, Texas Children’s Feigin Center, Baylor College of Medicine, Houston, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2007 in Development
Verified
Journal Article
Open access
PDF file
RMRicardo C. Moraes
Ricardo C. Moraes
XZXiaomei Zhang
Xiaomei Zhang
NHNikesha Harrington
Nikesha Harrington
JFJennifer Y. Fung
Jennifer Y. Fung
MWMeng-Fen Wu
Meng-Fen Wu
MLMichael T. Lewis
Michael T. Lewis
The hedgehog signaling network regulates pattern formation, proliferation, cell fate and stem/progenitor cell self-renewal in many organs. Altered hedgehog signaling is implicated in 20-25% of all cancers, including breast cancer. We demonstrated previously that heterozygous disruption of the gene encoding the patched-1 (PTCH1) hedgehog receptor, a negative regulator of smoothened (Smo) in the absence of ligand, led to mammary ductal dysplasia in virgin mice. We now show that expression of activated human SMO (SmoM2) under the mouse mammary tumor virus (MMTV) promoter in transgenic mice leads to increased proliferation, altered differentiation, and ductal dysplasias distinct from those caused by Ptch1 heterozygosity. SMO activation also increased the mammosphere-forming efficiency of primary mammary epithelial cells. However, limiting-dilution transplantation showed a decrease in the frequency of regenerative stem cells in MMTV-SmoM2 epithelium relative to wild type, suggesting enhanced mammosphere-forming efficiency was due to increased survival or activity of division-competent cell types under anchorage-independent growth conditions, rather than an increase in the proportion of regenerative stem cells per se. In human clinical samples, altered hedgehog signaling occurs early in breast cancer development, with PTCH1 expression reduced in ∼50% of ductal carcinoma in situ (DCIS) and invasive breast cancers (IBC). Conversely, SMO is ectopically expressed in 70% of DCIS and 30% of IBC. Surprisingly, in both human tumors and MMTV-SmoM2 mice, SMO rarely colocalized with the Ki67 proliferation marker. Our data suggest that altered hedgehog signaling may contribute to breast cancer development by stimulating proliferation, and by increasing the pool of division-competent cells capable of anchorage-independent growth.

1 November 2003 in Endocrinology
Verified
Journal Article
Closed access
RMR. C. Moraes
R. C. Moraes
ABA. Blondet
A. Blondet
KBK. Birkenkamp-Demtroeder
K. Birkenkamp-Demtroeder
JTJ. Tirard
J. Tirard
TOT. F. Orntoft
T. F. Orntoft
MBM. Bégeot
M. Bégeot
In the present study we developed a model of diet-induced obesity (DIO) in male C57 BL/6J mice using an 8-wk high fat diet. This model should better reflect the physiology of the majority of the human obese patients than mouse genetic models of obesity with defects in leptin or leptin signaling. At the end of the diet, DIO mice displayed an increased weight (20%) and higher leptin, insulin, glucose, and corticosterone plasma levels compared with mice fed a standard diet during the same period. Moreover, they became resistant to the central effect of peripheral administration of leptin. Oligonucleotide microarray studies were conducted in adipose tissue. They showed that a great number of genes are differentially expressed. The majority of these genes (69%) are down-regulated in DIO mice. Among those are genes encoding enzymes of the lipid metabolism or markers of adipocyte differentiation, enzymes involved in detoxification processes, as well as structural components of the cytoskeleton. Some other groups of genes displayed increased expression, such as those encoding inflammatory markers. The results of the microarray analysis were confirmed by semiquantitative RT-PCR studies run on a selected number of genes that were differentially expressed or not modified.

14 November 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
ZDZhijun Du
Zhijun Du
KPKatrina Podsypanina
Katrina Podsypanina
SHShixia Huang
Shixia Huang
AMAmanda McGrath
Amanda McGrath
MTMichael J. Toneff
Michael J. Toneff
YLYi Li
Yi Li
We have adapted the avian leukosis virus RCAS (replication-competent avian sarcoma-leukosis virus LTR splice acceptor)-mediated somatic gene transfer technique to introduce oncogenes into mammary cells in mice transgenic for the avian subgroup A receptor gene, tva , under control of the mouse mammary tumor virus (MMTV) promoter. Intraductal instillation of an RCAS vector carrying the polyoma middle T antigen (PyMT) gene (RCAS- PyMT ) induced multiple, oligoclonal tumors within 3 weeks in infected mammary glands of MMTV- tva transgenic mice. The rapid appearance of these tumors from a relatively small pool of infected cells (estimated to be ≈2 × 10 3 cells per gland by infection with RCAS carrying a GFP gene; RCAS- GFP ) was accompanied by a high fraction of cells positive for Ki67, Cyclin D1, and c-Myc, implying strong proliferation competence. Furthermore, the tumors displayed greater cellular heterogeneity than did tumors arising in MMTV- PyMT mice, suggesting that RCAS- PyMT transforms a relatively immature cell type. Infection of mice transgenic for both MMTV- Wnt-1 and MMTV- tva with RCAS virus carrying an activated Neu oncogene dramatically enhanced tumor formation over what is observed in uninfected bitransgenic animals. We conclude that infection of mammary glands with retrovirus vectors is an efficient means to screen candidate oncogenes for their capacity to initiate or promote mammary carcinogenesis in the mouse.

19 June 2008 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
XZXiaomei Zhang
Xiaomei Zhang
NHNikesha Harrington
Nikesha Harrington
RMRicardo C. Moraes
Ricardo C. Moraes
MWMeng-Fen Wu
Meng-Fen Wu
SHSusan G. Hilsenbeck
Susan G. Hilsenbeck
Michael LewisMichael Lewis
Michael Lewis

1 June 2009 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
BGBingnan Gu
Bingnan Gu
PSPeng Sun
Peng Sun
YYYuanyang Yuan
Yuanyang Yuan
RMRicardo C. Moraes
Ricardo C. Moraes
ALAihua Li
Aihua Li
XDXing Dai
Xing Dai
Recent studies have unequivocally identified multipotent stem/progenitor cells in mammary glands, offering a tractable model system to unravel genetic and epigenetic regulation of epithelial stem/progenitor cell development and homeostasis. In this study, we show that Pygo2, a member of an evolutionarily conserved family of plant homeo domain–containing proteins, is expressed in embryonic and postnatal mammary progenitor cells. Pygo2 deficiency, which is achieved by complete or epithelia-specific gene ablation in mice, results in defective mammary morphogenesis and regeneration accompanied by severely compromised expansive self-renewal of epithelial progenitor cells. Pygo2 converges with Wnt/β-catenin signaling on progenitor cell regulation and cell cycle gene expression, and loss of epithelial Pygo2 completely rescues β-catenin–induced mammary outgrowth. We further describe a novel molecular function of Pygo2 that is required for mammary progenitor cell expansion, which is to facilitate K4 trimethylation of histone H3, both globally and at Wnt/β-catenin target loci, via direct binding to K4-methyl histone H3 and recruiting histone H3 K4 methyltransferase complexes.

1 August 2005 in Endocrinology
Verified
Journal Article
Open access
PDF file
AMAline Martin
Aline Martin
RVRaphaël de Vittoris
Raphaël de Vittoris
VDValentin David
Valentin David
RMRicardo Moraes
Ricardo Moraes
MBMartine Bégeot
Martine Bégeot
TTThierry Thomas
Thierry Thomas
In vitro studies have demonstrated leptin-positive effects on the osteoblast lineage and negative effects on osteoclastogenesis. Therefore, we tested the hypothesis that leptin may prevent tail-suspension-induced bone loss characterized by an uncoupling pattern of bone remodeling, through both mechanisms. Female rats were randomly tail-suspended or not and treated either with ip administration of leptin or vehicle for 3, 7, and 14 d. As measured by dual energy x-ray absorptiometry, tail-suspension induced a progressive decrease in tibia-metaphysis bone mineral density, which was prevented by leptin. Histomorphometry showed that this was related to the prevention of the transient increase in osteoclast number observed with suspension at d 7. These effects could be mediated by the receptor activator of nuclear factor κB-ligand (RANKL)/osteoprotegerin (OPG) pathway since we observed using direct RT-PCR, a suspension-induced increase in RANKL gene expression in proximal tibia at d 3, which was counterbalanced by leptin administration with a similar 3-fold increase in OPG expression and a RANKL to OPG ratio close to nonsuspended conditions. In addition, leptin prevented the decrease in bone formation rate induced by tail-suspension at d 14. The latter could be related to the role of leptin in mediating the reciprocal differentiation between adipocytes and osteoblasts, because leptin concurrently blunted the disuse-induced increase in bone marrow adipogenesis. In summary, these data suggest that peripheral administration of leptin could prevent disuse-induced bone loss through, first, a major inhibitory effect on bone resorption and, second, a delayed effect preventing the decrease in bone formation.